
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Iron Hydroxide Adipate Tartrate
Therapeutic Area : Hematology
Study Phase : Phase III
Recipient : Nemysis
Deal Size : Undisclosed
Deal Type : Financing
Nemysis Limited Receives Investment from Kolinpharma via IGEA Holding S.p.A.
Details : The financing will support the clinical development of Iron Hydroxide Adipate Tartrate for iron deficiency in patients with celiac disease.
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Undisclosed
November 14, 2025
Lead Product(s) : Iron Hydroxide Adipate Tartrate
Therapeutic Area : Hematology
Highest Development Status : Phase III
Recipient : Nemysis
Deal Size : Undisclosed
Deal Type : Financing

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Iron Hydroxide Adipate Tartrate
Therapeutic Area : Hematology
Study Phase : Approved FDF
Sponsor : Nemysis
Deal Size : Undisclosed
Deal Type : Agreement
Nemysis Limited Signs with Kolinpharma SpA an IHAT Sales and Marketing Agreement
Details : Kolinpharma will market Iron Hydroxide Adipate Tartrate (IHAT), an oral iron supplement for iron deficiency, utilizing its existing sales network under the brand KIPFeR.
Product Name : KIPFeR
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Undisclosed
January 10, 2024
Lead Product(s) : Iron Hydroxide Adipate Tartrate
Therapeutic Area : Hematology
Highest Development Status : Approved FDF
Sponsor : Nemysis
Deal Size : Undisclosed
Deal Type : Agreement
